Vimarsana
Biggest News Aggregation in the World

Page 22 - Technical Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technical Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technical Evaluation Today - Breaking & Trending Today

FACILITIES MANAGEMENT ASSISTANT, G5 - Italy - Vimarsana News

FACILITIES MANAGEMENT ASSISTANT, G5 - Italy

Program/Project Management Job in Italy, requiring 5-9 years of experience, from UN; closing on 18 May 2023

Sikorsky to consider next steps as US Army FLRAA award protest rejected - Vimarsana News

Sikorsky to consider next steps as US Army FLRAA award protest rejected

The US Government Accountability Office has rejected Sikorsky-Boeing team's protest against Bell's V-280 Valor in the Future Long-Range Assault Aircraft competition.

Notice of extraordinary general meeting in Hamlet Pharma AB (publ) - Vimarsana News

Notice of extraordinary general meeting in Hamlet Pharma AB (publ)

The shareholders of Hamlet Pharma AB (publ) (“Hamlet Pharma” or the “Company”), reg. no. 556568-8958, are hereby invited to the extraordinary general meeting on Wednesday, 17 May 2023 at 14:00 at High Court Malmö, Malmöhusvägen 1, SE-211 18 Malmö, Sweden. Registration for the meeting will commence at 13:30.

Source: di.se
Solarisation of PM House, MPO: 10pc of bid price: one-time adjustment approved by AEDB - Vimarsana News

Solarisation of PM House, MPO: 10pc of bid price: one-time adjustment approved by AEDB

ISLAMABAD: The Board of Alternative Energy Development Board (AEDB) has accorded ex-post facto approval to a ...

Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections - Vimarsana News

Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections

This press release or the merger does not constitute an offer, either directly or indirectly in Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or the United States, or in any other jurisdiction where such offer under the laws and regulations of such relevant jurisdiction would be prohibited by applicable law. Shareholders who are not resident in Sweden and who wish to accept the proposed merger consideration must carry out closer investigations regarding the applicable legislation and possible tax consequences. The two pharmaceutical companies Hamlet Ph...

Source: di.se